Diversified science and technology company Danaher (NYSE: DHR) will be reporting results this Tuesday before market hours. Here’s what you need to know.

Danaher missed analysts’ revenue expectations last quarter, reporting revenues of $5.95 billion, up 3.7% year on year. It was a mixed quarter for the company, with a beat of analysts’ EPS estimates but a slight miss of analysts’ organic revenue estimates.

Is Danaher a buy or sell going into earnings? Read our full analysis here, it’s free for active Edge members.

This quarter, the market is expecting Danaher’s revenue to grow 2.8% year on year, in line with the 3.4% increase it recorded in the same quarter last year.

Analysts covering the company have generally reconfirmed their estimates over the last 30 days, suggesting they anticipate the business will stay the course heading into earnings. Danaher rarely misses Wall Street’s revenue estimates.

With Danaher being the first among its peers to report earnings this season, we don’t have anywhere else to look to get a hint at how this quarter will unfold for life sciences tools & services stocks. However, there has been positive investor sentiment in the segment, with share prices up 11% on average over the last month. Danaher is up 14.6% during the same time .

ONE MORE THING: The $21 AI Application Stock Wall Street Forgot. While Wall Street obsesses over who’s building AI, one company is already using it to print money. And nobody’s paying attention.

AI chip stocks trade at ridiculous valuations. This company processes a trillion consumer signals monthly using AI and trades at a third of the price. The gap won’t last. The institutions will figure it out. You need to see this first. Read the FREE Report Before They Notice.